Heartbeat.bio AG and Biotx.ai GmbH have partnered to identify and validate novel therapeutic targets in heart failure. The collaboration combines Biotx.ai’s causal mapping of the genome for target ...
Business Wire: Fauna Bio Announces First Candidate Nomination of Faun1083 for the Treatment of Heart Failure
Fauna Bio Announces First Candidate Nomination of Faun1083 for the Treatment of Heart Failure
The American Journal of Managed Care: STRONG-HF Data Suggest Bio-ADM Enhances Heart Failure Prognostic Value
Patients with the highest biologically active adrenomedullin (bio-ADM) levels at baseline were 114% more likely to die from any cause or be readmitted to the hospital for heart failure within 6 months ...